SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-24-034874
Filing Date
2024-02-14
Accepted
2024-02-14 06:26:25
Documents
3
Group Members
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUSTMACQUARIE MANAGEMENT HOLDINGS INC

Document Format Files

Seq Description Document Type Size
1 SC 13G d748551dsc13g.htm SC 13G 77467
2 EX-99.A d748551dex99a.htm EX-99.A 25881
3 EX-99.B d748551dex99b.htm EX-99.B 836
  Complete submission text file 0001193125-24-034874.txt   105864
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 24632007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000
Business Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G